Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Owens, Robert C.
Valenti, August J.
and
Wilcox, Mark H.
2007.
Antimicrobial Resistance: Problem Pathogens and Clinical Countermeasures.
p.
183.
Beaulieu, Mathieu
Williamson, David
Pichette, Gilbert
and
Lachaine, Jean
2007.
Risk of Clostridium difficile-Associated Disease Among Patients Receiving Proton-Pump Inhibitors in a Quebec Medical Intensive Care Unit.
Infection Control & Hospital Epidemiology,
Vol. 28,
Issue. 11,
p.
1305.
Kuijper, Ed J
van Dissel, Jaap T
and
Wilcox, Mark H
2007.
Clostridium difficile: changing epidemiology and new treatment options.
Current Opinion in Infectious Diseases,
Vol. 20,
Issue. 4,
p.
376.
Owens, Robert C.
and
Valenti, August J.
2007.
Clostridium difficile-Associated Disease in the New Millennium.
Infectious Diseases in Clinical Practice,
Vol. 15,
Issue. 5,
p.
299.
Marcos, Luis A.
and
DuPont, Herbert L.
2007.
Advances in defining etiology and new therapeutic approaches in acute diarrhea.
Journal of Infection,
Vol. 55,
Issue. 5,
p.
385.
Gerding, Dale N.
2007.
New Definitions Will Help, but Cultures are Critical for Resolving Unanswered Questions AboutClostridium difficile.
Infection Control & Hospital Epidemiology,
Vol. 28,
Issue. 2,
p.
113.
Wilcox, M.H.
2007.
Evidence for low risk of Clostridium difficile infection associated with tigecycline.
Clinical Microbiology and Infection,
Vol. 13,
Issue. 10,
p.
949.
Blossom, D. B.
and
McDonald, L. C.
2007.
The Challenges Posed by Reemerging Clostridium difficile Infection.
Clinical Infectious Diseases,
Vol. 45,
Issue. 2,
p.
222.
Ludlam, H.A.
and
Enoch, D.A.
2008.
Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?.
International Journal of Antimicrobial Agents,
Vol. 32,
Issue. 2,
p.
101.
Blondeau, J. M.
2008.
What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?.
Journal of Antimicrobial Chemotherapy,
Vol. 63,
Issue. 2,
p.
238.
Deshpande, Abhishek
Pant, Chaitanya
Jain, Anil
Fraser, Thomas G.
and
Rolston, David D. K.
2008.
Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence.
Current Medical Research and Opinion,
Vol. 24,
Issue. 2,
p.
329.
McFarland, Lynne V
2008.
Update on the changing epidemiology of Clostridium difficile-associated disease.
Nature Clinical Practice Gastroenterology & Hepatology,
Vol. 5,
Issue. 1,
p.
40.
Åkerlund, Thomas
Persson, Ingela
Unemo, Magnus
Norén, Torbjörn
Svenungsson, Bo
Wullt, Marlene
and
Burman, Lars G.
2008.
Increased Sporulation Rate of Epidemic
Clostridium difficile
Type 027/NAP1
.
Journal of Clinical Microbiology,
Vol. 46,
Issue. 4,
p.
1530.
Owens, Jr., Robert C.
Donskey, Curtis J.
Gaynes, Robert P.
Loo, Vivian G.
and
Muto, Carlene A.
2008.
Antimicrobial‐Associated Risk Factors forClostridium difficileInfection.
Clinical Infectious Diseases,
Vol. 46,
Issue. s1,
p.
S19.
van der Kooi, T. I. I.
Koningstein, M.
Lindemans, A.
Notermans, D. W.
Kuijper, E.
van den Berg, R.
Boshuizen, H.
Filius, P. M. G.
and
van den Hof, S.
2008.
Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027.
Journal of Medical Microbiology
,
Vol. 57,
Issue. 6,
p.
709.
Spigaglia, Patrizia
Barbanti, Fabrizio
Mastrantonio, Paola
Brazier, Jon S.
Barbut, Frédéric
Delmée, Michel
Kuijper, Ed
and
R. Poxton, Ian
2008.
Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe.
Journal of Medical Microbiology
,
Vol. 57,
Issue. 6,
p.
784.
Weiss, Karl
2009.
Clostridium difficile and fluoroquinolones: is there a link?.
International Journal of Antimicrobial Agents,
Vol. 33,
Issue. ,
p.
S29.
Spigaglia, Patrizia
Barbanti, Fabrizio
Louie, Thomas
Barbut, Frédéric
and
Mastrantonio, Paola
2009.
Molecular Analysis of the
gyrA
and
gyrB
Quinolone Resistance-Determining Regions of Fluoroquinolone-Resistant
Clostridium difficile
Mutants Selected In Vitro
.
Antimicrobial Agents and Chemotherapy,
Vol. 53,
Issue. 6,
p.
2463.
Saxton, Katie
Baines, Simon D.
Freeman, Jane
O'Connor, Rachael
and
Wilcox, Mark H.
2009.
Effects of Exposure of
Clostridium difficile
PCR Ribotypes 027 and 001 to Fluoroquinolones in a Human Gut Model
.
Antimicrobial Agents and Chemotherapy,
Vol. 53,
Issue. 2,
p.
412.
Kallen, Alexander J.
Thompson, Angela
Ristaino, Polly
Chapman, Leigh
Nicholson, Ainsley
Sim, Bich-Thuy
Lessa, Fernanda
Sharapov, Umid
Fadden, Elaine
Boehler, Richard
Gould, Carolyn
Limbago, Brandi
Blythe, David
and
McDonald, L. Clifford
2009.
Complete Restriction of Fluoroquinolone Use to Control an Outbreak ofClostridium difficileInfection at a Community Hospital.
Infection Control & Hospital Epidemiology,
Vol. 30,
Issue. 3,
p.
264.